Controlled and Sustained Drug Release Using Advanced Polymeric Systems: Formulation Design and Recent Pharmaceutical Applications
DOI:
https://doi.org/10.64882/ijrt.v14.i1.1802Keywords:
Biodegradable polymers, Zero-order kinetics, Osmotic pumps, Hydrogels, PLGA microspheres, Matrix tablets, Polymeric drug delivery, Sustained release, Controlled releaseAbstract
Polymer-based controlled- and sustained-release drug delivery systems have become the mainstay of modern pharmaceutical development, offering the ability to maintain therapeutically effective drug concentrations for prolonged periods, reduce dosing frequency, improve patient adherence and, in many cases, lower peak-related toxicity. Fundamental principles of controlled and sustained release are outlined together with the physical mechanisms that govern drug release from polymeric matrices, reservoirs, particulate systems, hydrogels, osmotic devices and implants. Natural, synthetic, biodegradable, non-biodegradable and stimuli-responsive polymers are surveyed with their principal characteristics and release-controlling roles, and formulation strategies including matrix and reservoir designs, coated multiparticulate systems, ion-exchange resins, osmotic pumps, polymeric microspheres and nanoparticles, hydrogels, and long-acting implants are examined. Mathematical models used to describe polymeric drug release — zero-order, first-order, Higuchi, Korsmeyer–Peppas, Hixson–Crowell and Weibull — are summarised, together with the characterisation workflow that supports formulation development. Recent pharmaceutical applications across oral, injectable, transdermal, ocular, implantable, pulmonary and anticancer routes are discussed. The review closes with a critical assessment of the practical advantages, limitations and future directions of polymeric controlled-release technology, including stimuli-responsive smart polymers, three-dimensional-printed dosage forms and long-acting implants for chronic disease management.
References
Almoshari Y. Osmotic pump drug delivery systems—a comprehensive review. Pharmaceuticals (Basel). 2022;15(11):1430.
Anselmo AC, Mitragotri S. Nanoparticles in the clinic. Bioeng Transl Med. 2016;1(1):10-29.
Bhargava A, Rathore RPS, Tanwar YS, Gupta S, Bhaduka G. Oral sustained release dosage form: an opportunity to prolong the release of drug. Int J Adv Res Pharm Bio Sci. 2013;3(1):7-14.
Bruschi ML (ed). Strategies to modify the drug release from pharmaceutical systems. Cambridge: Woodhead Publishing; 2015.
Bruschi ML, de Freitas O. Oral bioadhesive drug delivery systems. Drug Dev Ind Pharm. 2005;31(3):293-310. [Foundational reference cited throughout 2011-2022 mucoadhesive controlled release literature]
Colombo P, Bettini R, Santi P, Peppas NA. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today. 2000;3(6):198-204. [Foundational reference for HPMC matrix mechanisms cited throughout the review period]
Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161(2):505-522.
Fu Y, Kao WJ. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin Drug Deliv. 2010;7(4):429-444.
Goyanes A, Buanz ABM, Basit AW, Gaisford S. Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm. 2014;476(1-2):88-92.
Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev. 2016;116(4):2602-2663.
Kanamala M, Wilson WR, Yang M, Palmer BD, Wu Z. Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review. Biomaterials. 2016;85:152-167.
Kapoor DN, Bhatia A, Kaur R, Sharma R, Kaur G, Dhawan S. PLGA: a unique polymer for drug delivery. Ther Deliv. 2015;6(1):41-58.
Karimi M, Ghasemi A, Sahandi Zangabad P, Rahighi R, Moosavi Basri SM, Mirshekari H, et al. Smart micro/nanoparticles in stimulus-responsive/controlled release drug delivery systems. Chem Soc Rev. 2016;45(5):1457-1501.
Keraliya RA, Patel C, Patel P, Keraliya V, Soni TG, Patel RC, Patel M. Osmotic drug delivery system as a part of modified release dosage form. ISRN Pharm. 2012;2012:528079.
Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75(1):1-18.
Li J, Mooney DJ. Designing hydrogels for controlled drug delivery. Nat Rev Mater. 2016;1(12):16071.
Makadia HK, Siegel SJ. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel). 2011;3(3):1377-1397.
Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12(11):991-1003.
Nair LS, Laurencin CT. Biodegradable polymers as biomaterials. Prog Polym Sci. 2007;32(8-9):762-798.
Norouzi M, Nazari B, Miller DW. Injectable hydrogel-based drug delivery systems for local cancer therapy. Drug Discov Today. 2016;21(11):1835-1849.
Owen A, Rannard S. Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: insights for applications in HIV therapy. Adv Drug Deliv Rev. 2016;103:144-156.
Palugan L, Cerea M, Zema L, Gazzaniga A, Maroni A. Coated pellets for oral colon delivery. J Drug Deliv Sci Technol. 2015;25:1-15.
Peppas NA, Narasimhan B. Mathematical models in drug delivery: how modeling has shaped the way we design new drug delivery systems. J Control Release. 2014;190:75-81.
Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261-1268.
Ratnaparkhi MP, Gupta JP. Sustained release oral drug delivery system — an overview. Int J Pharma Res Rev. 2013;2(3):11-21.
Ratnaparkhi MP, Gupta Jyoti P. Sustained release oral drug delivery system — an overview. Int J Pharm Res Rev. 2013;2(3):11-21. [Formulation of oral sustained-release matrix tablets]
Sharma S. Osmotic controlled drug delivery system. Latest Rev. 2008;6:3.
Siepmann J, Siepmann F. Modeling of diffusion controlled drug delivery. J Control Release. 2012;161(2):351-362.
Sood N, Bhardwaj A, Mehta S, Mehta A. Stimuli-responsive hydrogels in drug delivery and tissue engineering. Drug Deliv. 2016;23(3):758-780.
Timmins P, Pygall SR, Melia CD (eds). Hydrophilic matrix tablets for oral controlled release. AAPS Advances in the Pharmaceutical Sciences Series, Vol. 16. New York: Springer; 2014.
Ummadi S, Shravani B, Rao NGR, Reddy MS, Sanjeev B. Overview on controlled release dosage form. Int J Pharma Sci. 2013;3(4):258-269.
Wang Y, Qu W, Choi SH. FDA's poly(lactic-co-glycolic acid) research program and regulatory outcomes. AAPS J. 2016;18(4):907-909.
Downloads
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.




